Femasys Inc. FEMY

Set alert

Price alert · FEMY

All alert types
1.32 USD -0.05 -3.65%

At close · Nov 2

1.32 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
1.30 × 1
Ask
1.33 × 2
1.29 Day range 1.42
1.29 52-week range 22.20
YTD
-88.54%
1 year
-89.64%
Open
1.37
Prev close
1.37
Mkt cap
11.06M
Vol
129.86K
Avg vol
735.19K
EPS
-3.18
P/E
0.00
Div yield
0.00%
More statistics
Low
1.29
High
1.42
Forward P/E
-2.33
Beta
-2.83
Short ratio
3.67
Inst. own
7.26%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.14
200-d avg
1.22
1y target
8.25

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for FEMY has not been loaded yet. Try again in a moment.

Discussion (310)

Sign in to join the discussion

jay FEMY 1 week ago #1

$FEMY Drastic actions have to be taken by
the new group of investors and the BD

  1. Excessive executive compensation be reduced by 60% and add a bonus based on
    Sales growth and profitability.
  2. Replace CEO and VP of sales.

This will reduce the cash burn and possibly stabilize the stock price.

jay FEMY 3 weeks ago #2

$FEMY Cathy cleaned out the 1st group of
investors, now she is cleaning out this new group of investors. Femseed was approved a year ago we should have at least $5M
sales by now. We need a new competent, experienced and go getter CEO immediately to change direction of the stock.

jay FEMY 1 month ago #3

$FEMY on top of that this management is grossly over paid. Based on the size and profitability they should be paid less than half of what they are being paid. Anything more should be in the way of incentive pay based on sales growth and profitability.

jay FEMY 1 month ago #4

$FEMY company’s success depends on its management. New investors should open their eyes and replace this incompetent management led by Cathy with someone competent, experienced and qualified.

jay FEMY 2 months ago #5

$FEMY this is not a significant news. Approval of modular PMA pathway means
FDA will review parts of the application
In stages. This lets the company submit
Non-Clinical and manufacturing data in segments, while the clinical trials continue to progress.

jay FEMY 3 months ago #6

FEMY CEO Cathy and top executives are sucking up the remaining cash from the
Company with their inflated, unrealistic and ridiculous compensation packages. Time
to fire these leeches and replace with a
new experienced and smart ceo and team.
Unless and until this happens this company
will not get reasonable financing and will
be liquidated.

jay FEMY 3 months ago #7

FEMY unless and until this incompetent
over paid CEO is fired, there is no future
for the company, the only direction for stock price will be down. Need a smart competent New CEO to turnaround this
Company ASAP

jay FEMY 4 months ago #8

Cathy needs to be fired immediately. She is not only incompetent and stupid but also
Unlucky

jay FEMY 5 months ago #9

$FEMY Nasdaq notified them with 7/15 deadline. Does anyone know the date of the reverse split.

Member FEMY 7 months ago #10

Good news anytime soon ??